These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 19902860

  • 1. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
    Bhattacharya S, Vijayasekar C, Worlding J, Mathew G.
    Acta Gastroenterol Belg; 2009; 72(3):289-95. PubMed ID: 19902860
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
    Zidan J, Haim N, Beny A, Stein M, Gez E, Kuten A.
    Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 8. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S, Benson AB, Engelking C, Catalano R, Field M, Kornblau SM, Mitchell E, Rubin J, Trotta P, Vokes E.
    J Clin Oncol; 1998 Sep; 16(9):3169-78. PubMed ID: 9738589
    [Abstract] [Full Text] [Related]

  • 9. [Management of chemotherapy induced diarrhea].
    Schultz M, Schölmerich J, Kullmann F.
    Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H.
    Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Octreotide in the management of treatment-related diarrhoea.
    Baillie-Johnson HR.
    Anticancer Drugs; 1996 Jan; 7 Suppl 1():11-5. PubMed ID: 8822080
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
    Keefe DM, Elting LS, Nguyen HT, Grunberg SM, Aprile G, Bonaventura A, Selva-Nayagam S, Barsevick A, Koczwara B, Sonis ST.
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.